Monjuvi 200 mg lyophilized powder for injection Images
Generic Name: tafasitamab
This medication has been identified as Monjuvi 200 mg lyophilized powder for injection. It is supplied by MorphoSys US Inc.
Monjuvi is used in the treatment of Diffuse Large B-Cell Lymphoma; Follicular Lymphoma and belongs to the drug class CD19 monoclonal antibodies. Monjuvi 200 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Monjuvi
- Generic Name
- tafasitamab
- Strength
- 200 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- CD19 monoclonal antibodies
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- MorphoSys US Inc.
- National Drug Code (NDC)
- 73535-0208
See also:
Rituxan
Rituxan is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat B-cell precursor acute lymphoblastic leukemia (ALL), large B-cell ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma (FL) in adults. It is a p ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Xpovio
Xpovio is used to treat multiple myeloma (MM) or relapsed/refractory diffuse large B-cell lymphoma ...
Tazverik
Tazverik (tazemetostat) used for the treatment of patients with epithelioid sarcoma and follicular ...
More about Monjuvi (tafasitamab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD19 monoclonal antibodies
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.